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ERp57, in complex with the lectins calreticulin and cal-
nexin, catalyzes disulphide bond formation inN-glyco-
sylatedproteins. In this issueofStructure, Kozlov et al.
(2006) report the structure of the noncatalytic domains
ofERp57andcharacterize thecalnexin interaction site.
Native disulphide bond formation in the endoplasmic
recticulum (ER) is complex, occurring via multiple paral-
lel pathways. While some of the participants in this cellu-
lar process are known, their individual roles are still
largely confused. However, the rate-limiting folding steps
for proteins that contain multiple disulphides are late-
stage isomerization reactions, where disulphide bond
formation is linked to conformational changes in protein
substrates with substantial regular secondary structure,
and these reactions are catalyzed only by members of
the protein disulphide isomerase (PDI) family.
PDI family members differ considerably between dif-
ferent organisms. There are at least 17 human PDI family
members (Ellgaard and Ruddock, 2005), most of which
are poorly characterized with little or nothing being
known about their physiological function(s). Bovine PDI
was the first protein folding catalyst reported over
40 years ago (Goldberger et al., 1963), but significant
details of the mechanisms of action of the PDI family
are still unknown. In part, this is due to the complexities
of its activities and substrates, but work in the field has
also been severely hampered by the inability for over
30 years to crystallize catalytically active PDI family
members or multidomain constructs. Very recently the
first structure of a PDI was published, Pdi1p from S. cer-
evisiae, which revealed that each of the four domains, a,
b,b0, and a0, has a thioredoxin fold (Tian et al., 2006). This
2.4 A˚ structure gave important insights into the domain
organization of this protein and will undoubtedly affect
many functional studies. Following hard on the heels
of that study, the group of Kalle Gehring and coworkers
has solved the structure of the noncatalytic bb0 domains
of ERp57 to 2.0 A˚ (Kozlov et al., 2006).
After PDI itself, ERp57 is the most widely studied PDI
family member. It is thought to be dedicated to the fold-
ing of N-glycosylated proteins, with the specificity for
substrates arising through its interactions with the ER-
resident lectins calreticulin (CRT) and calnexin (CNX).
In their detailed and extensive study, Kozlov and co-
workers have not only solved the crystal structure of the
bb0 domains of ERp57 (Figure 1), but they have also ob-
tained information on full-length ERp57 via small-angle
X-ray scattering (SAXS; Kozlov et al., 2006). Both do-
mains unsurprisingly adopt a thioredoxin fold, as seen
in Pdi1p (Tian et al., 2006), but there are important differ-
ences between the two structures, not least the orienta-
tion of the domains with respect to each other. However,
it is unclear if this is an ERp57-specific effect or if crystal
packing plays a role, especially since the Pdi1p structure
appears to have the b domain of one Pdi1p moleculelocated in the substrate binding groove formed between
the four domains of another Pdi1p molecule (Tian et al.,
2006). ERp57 also contains two insertions in the b do-
main, including an enlarged b4-b5 loop, which plays
a role inCNX interactions (see below),while theb0 domain
of Pdi1p contains a significant insertion between b5-a4
of as yet unknown function. Looking at the full protein,
SAXS data implies that the average conformation of
ERp57 in solution closely resembles that of Pdi1p
(Kozlov et al., 2006; Tian et al., 2006).
NMR and ITC studies (Kozlov et al., 2006) allowed the
identification of the CNX interaction site on ERp57 as
a conserved positively charged region on the b0 domain,
along with spatially adjacent residues from the enlarged
b4-b5 loop in the b domain. These studies also impli-
cated a conserved negatively charged region at the tip
of the P domain of CNX in the CNX-ERp57 interaction,
results which resemble those previously reported for
CRT-ERp57 interactions (Frickel et al., 2002). While the
association between CNX and ERp57 is primarily elec-
trostatic in nature, other factors must also participate,
since a single point mutation (M347A) in CNX also com-
pletely abrogated the interaction (Kozlov et al., 2006).
Recently, the ERp57 knockout was described. While
the mouse knockout was embryonic lethal, consistent
with the key role in N-glycoprotein folding and quality
control reported for ERp57 (reviewed in Ellgaard and
Helenius, 2003), the results from knockout cell lines
showed remarkably little phenotype (Garbi et al., 2006;
Solda et al., 2006). This lack of phenotype probably re-
sults from functional redundancy between the 17 human
PDI family members, specifically the potential for ERp72
to replace ERp57 (Ellgaard and Ruddock, 2005). When
mapped onto the structure of ERp57 bb0, sequence con-
servation between ERp57 and ERp72 looks similar to
that reported for the conservation of surface residues
in ERp57, including in the CNX interaction site (see
above). Hence, it is likely that ERp72 can interact with
CRT/CNX under normal physiological conditions as
well as in the ERp57 knockout cell line (Solda et al., 2006).
The mechanism of action of the PDI family as catalysts
of native disulphide bond formation in polypeptide fold-
ing requires the ability to catalyze disulphide-dithiol
exchange and to bind nonnative proteins. While ERp57
almost certainly has substrate binding sites in the cata-
lytically active a and a0 domains as per PDI (Koivunen
et al., 2005), the primary substrate specificity for protein
substrates arises through its interaction with CRT/CNX,
which in turn bind monoglucosylated protein substrates.
CNX binding by ERp57 is critical for ERp57-catalyzed
refolding of N-glycosylated substrates, but it does not
stimulate the reduction of di(o-aminobenzyl)-labeled ox-
idized glutathione by ERp57, suggesting that CNX/CRT
serves to bind and position substrates rather than di-
rectly stimulating the oxidoreductase activity of ERp57
(Kozlov et al., 2006). However, the unusual elongated
structure of the P domain of CNX/CRT (Schrag et al.,
2001; Ellgaard et al., 2001) and the positioning of the
CNX/CRT binding site on the opposite face of ERp57
relative to the catalytic thiols (Figure 1A) offer another
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(A) Structure of CNX (Schrag et al., 2001) and ERp57 (constructed from the structures of ERp57 bb0 and the a and a0 domains of Pdi1p [Tian
et al., 2006] as per Kozlov et al. [2006]), with the mutual interaction sites (Kozlov et al., 2006) indicated with arrows. CNX is shown in yellow, and
ERp57 in blue. The ERp57 bb0 coordinates (Kozlov et al., 2006) were generously communicated by the authors prior to publication.
(B) Schematic of the CNX-ERp57-substrate complex. Note that the orientation of CNX with respect to ERp57 is currently unknown. ERp57
binds nonnative protein substrates and forms mixed disulphides with the substrate via its catalytic a and/or a0 domains, while CNX binds
the monoglucosylated N-glycan (Glc1-Man9-GlcNAc2, shown stylized in red) via its glycan binding domain. Any movement of CNX relative
to ERp57, for example, flexing of the elongated hairpin P domain or of the a and a0 domains of ERp57 relative to each other, will result in
conformational changes in the bound substrate. Such motions could potentially allow ERp57 access to buried cysteines and/or disulphides.interestingmechanisticpossibility.SincePDIfamilymem-
bers have to access buried thiol residues in polypeptide
substrates with substantial regular secondary structure,
the action of ERp57 with CNX/CRT must, in some way,
be able to trigger conformational changes in bound sub-
strate. As CNX/CRT and ERp57 have a limited interaction
site far removed from their substrate binding sites (Fig-
ure 1B; Kozlov et al., 2006), there is the potential for the
movement of the substrate binding sites of CNX/CRT
and ERp57 with respect to each other. Any such move-
ment of CNX/CRT with respect to ERp57 could deform
the mutually bound N-glycosylated polypeptide sub-
strate, especially if, like most substrates for ERp57, it
lacks stable tertiary structure. Such speculation requires
either structural or modeling studies on the dynamics of
the interaction between CNX/CRT and ERp57, something
which the Kozlov et al. (2006) paper brings into reach.
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